Evidence map›Paper›PMID 34093593›Full record

ReviewFrontiers in immunology2021

Inflammatory Regulation of CNS Barriers After Traumatic Brain Injury: A Tale Directed by Interleukin-1.

Colleen N Bodnar, James B Watson, Emma K Higgins, Ning Quan, Adam D Bachstetter

Abstract readReview
In one paragraph

Review in Frontiers in immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. CSF1R and IL1R1 inhibitors synergistically attenuate the early pathogenesis of traumatic brain injury in mice.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2026
    Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Review
  17. Review
  18. Article
  19. Review
  20. Choroid Plexus Pathophysiology.Annual review of pathology · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Colleen N BodnarDepartment of Neuroscience, University of Kentucky, Lexington, KY, United States.
James B WatsonDepartment of Neuroscience, University of Kentucky, Lexington, KY, United States.
Emma K HigginsDepartment of Neuroscience, University of Kentucky, Lexington, KY, United States.
Ning QuanDepartment of Biomedical Science, Charles E. Schmidt College of Medicine and Brain Institute, Florida Atlantic University, Jupiter, FL, United States.
Adam D BachstetterDepartment of Neuroscience, University of Kentucky, Lexington, KY, United States.

Funding

Neurobiology of CNS Injury and RepairT32NS077889 · NINDS · UNIVERSITY OF KENTUCKY · PI Warren Joseph Alilain, JOHN C GENSEL · 2012 to 2026
$2.4M
Cell-Specific Actions of IL-1 / IL-1R1 Signaling Following Traumatic Brain InjuryR01NS103785 · NINDS · UNIVERSITY OF KENTUCKY · PI BACHSTETTER, ADAM D · 2019 to 2023
$1.6M
SLC9A1 and Neurodegenerative DiseaseR21AG059123 · NIA · UNIVERSITY OF KENTUCKY · PI BACHSTETTER, ADAM D, MURPHY, MICHAEL PAUL · 2019 to 2020
$421k
Pumping iron: Loss of iron homeostasis causes microglia degeneration in ADR21AG066865 · NIA · UNIVERSITY OF KENTUCKY · PI BACHSTETTER, ADAM D · 2020 to 2020
$421k
Understanding the immune response after mild TBI: Do endothelial cells play a major role?F31NS116912 · NINDS · UNIVERSITY OF KENTUCKY · PI BODNAR, COLLEEN · 2020 to 2021
$87k
NIA NIH HHS R21 AG059123NIA NIH HHS R21 AG066865NINDS NIH HHS F31 NS116912NINDS NIH HHS R01 NS103785NINDS NIH HHS T32 NS077889
6 · The paper itself

Abstract

Several barriers separate the central nervous system (CNS) from the rest of the body. These barriers are essential for regulating the movement of fluid, ions, molecules, and immune cells into and out of the brain parenchyma. Each CNS barrier is unique and highly dynamic. Endothelial cells, epithelial cells, pericytes, astrocytes, and other cellular constituents each have intricate functions that are essential to sustain the brain's health. Along with damaging neurons, a traumatic brain injury (TBI) also directly insults the CNS barrier-forming cells. Disruption to the barriers first occurs by physical damage to the cells, called the primary injury. Subsequently, during the secondary injury cascade, a further array of molecular and biochemical changes occurs at the barriers. These changes are focused on rebuilding and remodeling, as well as movement of immune cells and waste into and out of the brain. Secondary injury cascades further damage the CNS barriers. Inflammation is central to healthy remodeling of CNS barriers. However, inflammation, as a secondary pathology, also plays a role in the chronic disruption of the barriers' functions after TBI. The goal of this paper is to review the different barriers of the brain, including (1) the blood-brain barrier, (2) the blood-cerebrospinal fluid barrier, (3) the meningeal barrier, (4) the blood-retina barrier, and (5) the brain-lesion border. We then detail the changes at these barriers due to both primary and secondary injury following TBI and indicate areas open for future research and discoveries. Finally, we describe the unique function of the pro-inflammatory cytokine interleukin-1 as a central actor in the inflammatory regulation of CNS barrier function and dysfunction after a TBI.

Indexed as

AnimalsAnti-Inflammatory AgentsBlood-Brain BarrierBlood-Retinal BarrierBrain Injuries, TraumaticHumansInflammationInflammation MediatorsInterleukin-1MeningesReceptors, Interleukin-1 Type ISignal TransductionAnti-Inflammatory AgentsInflammation MediatorsInterleukin-1Receptors, Interleukin-1 Type IedemagliaIL1R1interleukin-1 receptor 1neuroimmunologyneuroinflammationneurotrauma

Identifiers

PMID34093593
PMCPMC8176952

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.